Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5α-Reductase inhibitors can negatively impact sexual function.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.